Engineered peptides show promise in cancer immunotherapy

[News]

In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.

More... (https://www.news-medical.net/news/20240422/Engineered-peptides-show-promise-in-cancer-immunotherapy.aspx)